Medicare will keep covering Roche's Avastin
Thursday, June 30, 2011 - 17:30
in Health & Medicine
WASHINGTON (Reuters) - Medicare will continue paying for Roche Holding's drug Avastin for breast cancer, regardless of what health regulators decide about the medicine's future, a spokesman said on Thursday.